Sultopride (LIN-1418)
(Synonyms:舒托必利;舒多必利;吡乙磺苯酰胺;盐酸舒托必利;N-[(1-乙基-吡咯烷基)甲基]-5-(乙基磺酰基)-2-甲氧基苯甲酰胺盐酸盐)
目录号 : KG12584
CAS No. : 53583-79-2
纯度 : 98%
Sultopride is a selective antagonist of dopamine D2 receptor.
Sultopride is a selective antagonist of dopamine D2 receptor. DOPAC and HVA levels in the striatum, the nucleus accumbens and the medial prefrontal cortex are higher in the rats treated with Sultopride and sulpiride than those of the controls. In the striatum, DOPAC and HVA levels are higher in the Sultopride-treated rats than the sulpiride-treated rats (p<0.05). In the nucleus accumbens, DOPAC levels are higher in the Sultopride-treated rats than sulpiride treated rats (p<0.05). In the Sultopride-treated rats, DOPAC and HVA levels are higher in the striatum or in the nucleus accumbens than in the medial prefrontal cortex (p<0.05).
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 分子式 |
C17H26N2O4S
|
| 分子量 |
354.46
|
| CAS号 |
53583-79-2
|
| 中文名称 |
舒托必利
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|